Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 1469-1476, March 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seed, T. M.
Right arrow Articles by Kaspar, L. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seed, T. M.
Right arrow Articles by Kaspar, L. V.

Acquired Radioresistance of Hematopoietic Progenitors (Granulocyte/Monocyte Colony-forming Units) during Chronic Radiation Leukemogenesis1

Thomas M. Seed2 and Lillian V. Kaspar

Biological and Medical Research Division, Argonne National Laboratory, Argonne, Illinois 60439-4833

Protracted exposure of dogs to low daily doses of whole-body {gamma}-radiation (7.5 cGy/day for duration of life) elicits a high incidence of myeloid leukemia or related myeloproliferative disorders. Under such exposure, vital hematopoietic progenitors [granulocyte/monocyte colony-forming units in agar (CFU-GM)] acquire increased radioresistance along with renewed proliferative capacity at an early phase of evolving myeloid leukemia. To further characterize the expression of acquired radioresistance by CFU-GM, we evaluated the effects of various exposure rates, cumulative radiation doses, and times of exposure and postexposure in several groups of long-lived dogs under two conditions of irradiation: (a) continuous, duration-of-life exposures at dose rates of 0.3–7.5 cGy/day; and (b) discontinuous, fraction-of-life exposures at dose rates of 3.8–26.3 cGy/day, with cumulative doses of 450–3458 cGy and postexposure times of 14–4702 days. Results indicated that (a) under protracted continuous irradiation, the degree of radioresistance expressed by CFU-GM in vitro increased markedly in a biphasic pattern with rising daily rates of exposure; (b) under discontinuous, fraction-of-life exposure regimens, elevated levels of radioresistance were expressed and stably maintained by CFU-GM only following large radiation doses accumulated at high dose rates; and (c) with extended postexposure times, the magnitude of expressed radioresistance appeared to wane. These results continue to support the hypothesis that the acquisition of radioresistance and associated repair functions by vital lineage-committed progenitors, under the strong selective and mutagenic pressure of chronic irradiation, is tied temporally and causally to leukemogenic transformation elicited by radiation exposure.

1 This work was supported by the U.S. Department of Energy, Office of Health and Environmental Research, under Contract W-31-109-ENG-38 and by U.S. Department of Health and Human Service Interagency Agreement Y01-CP-50503.

2 To whom all requests for reprints should be addressed, at Radiation Hematology Group, Biological and Medical Research Division (BIM/202), Argonne National Laboratory, 9700 South Cass Avenue, Argonne, IL 60439-4833.

Received 9/13/91. Accepted 1/ 8/92.




This article has been cited by other articles:


Home page
BloodHome page
J. M. Zaucha, C. Yu, G. Mathioudakis, K. Seidel, G. Georges, G. Sale, M.-T. Little, B. Torok-Storb, and R. Storb
Hematopoietic responses to stress conditions in young dogs compared with elderly dogs
Blood, July 15, 2001; 98(2): 322 - 327.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.